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REPORT
Penetrance of Craniofacial Anomalies in Mouse Models of Smith-
Magenis Syndrome Is Modiﬁed by Genomic Sequence
Surrounding Rai1: Not All Null Alleles Are Alike
Jiong Yan, Weimin Bi, and James R. Lupski
Craniofacial abnormality is one of the major clinical manifestations of Smith-Magenis syndrome (SMS). Previous analyses
in a mixed genetic background of several SMS mouse models—including Df(11)17/+ and Df(11)17-1/+, which have 2-
Mb and 590-kb deletions, respectively, and Rai15/+—revealed that the penetrance of the craniofacial phenotype appears
to be inﬂuenced by deletion size and genetic background. We generated an additional strain with a 1-Mb deletion
intermediate in size between the two described above. Remarkably, the penetrance of its craniofacial anomalies in the
mixed background was between those of Df(11)17 and Df(11)17-1. We further analyzed the deletion mutations and the
Rai15/+ allele in a pure C57BL/6 background, to control for nonlinked modiﬁer loci. The penetrance of the craniofacial
anomalies was markedly increased for all the strains in comparison with the mixed background. Mice with Df(11)17 and
Df(11)17-1 deletions had a similar penetrance, suggesting that penetrance may be less inﬂuenced by deletion size,whereas
that of Rai15/+ mice was signiﬁcantly lower than that of the deletion strains.We hypothesize that potential trans-regulatory
sequence(s) or gene(s) that reside within the 590-kb genomic interval surrounding Rai1 are the major modifying genetic
element(s) affecting the craniofacial penetrance. Moreover, we conﬁrmed the inﬂuence of genetic background and dif-
ferent deletion sizes on the phenotype. The complicated control of the penetrance for one phenotype in SMS mouse
models provides tools to elucidate molecular mechanisms for penetrance and clearly shows that a null allele caused by
chromosomal deletion can have different phenotypic consequences than one caused by gene inactivation.
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A characteristic craniofacial phenotype is presented in
many genetic syndromes, which enables an initial diag-
nosis by experienced clinical geneticists and dysmor-
phologists.1 The major facial features in Smith-Magenis
syndrome (SMS [MIM 182290]) include midface hypo-
plasia, a broad nasal bridge, prognathia, a down-turned
mouth, and bulky philtral pillars.2–4 Both anthropometric
measurements and three-dimensional facial morphology
analyses quantitatively conﬁrmed these features.2,5 The
characteristic facial appearance enables discrimination
between patients with SMS and unaffected controls and
between SMS and other syndromes, with the ocular and
nasal regions revealing the most-signiﬁcant differences.5
These ﬁndings are consistent with the abnormalities ob-
served in the SMS mouse models, indicating that studies
in the mouse models may reveal insights into the path-
ogenesis of the SMS craniofacial phenotype, as has re-
cently been suggested for studies of Williams-Beuren
syndrome.6
SMS is a multiple congenital anomaly and mental re-
tardation condition due to a heterozygous 3.7-Mb inter-
stitial deletion on chromosome 17p11.2 in the majority
(70%–80%) of patients.7–10 Prominent SMS features in-
clude developmental delay, mental retardation, craniofa-
cial and skeletal defects, and neurobehavioral anoma-
lies.3,4 Patients with deletions of unusual size have enabled
the reﬁnement of the SMS critical region (SMCR) to an
∼1.1-Mb interval.9,10 The identiﬁcation of frameshift and
nonsense mutations in RAI1 (MIM 607642), a retinoic
acid–inducible gene that maps within the SMCR, in sev-
eral patients with SMS without detectable deletions sug-
gests that it is the major gene responsible for the SMS
phenotype, through haploinsufﬁciency.11–14 The variation
of phenotypes, even in patients with the same deletion
size,8 and the small number of patients with RAI1 point
mutations make it challenging to determine whetherRAI1
is the only gene responsible for the phenotype.
To take advantage of the high conservation between the
human SMS deletion interval and the mouse syntenic
region,9,15 several mouse models have been constructed,
including Df(11)17, a strain with an ∼2-Mb chromosome-
engineered deletion; Df(11)17-1, with a 590-kb deletion;
Df(11)17-2 and -3, both with a 595-kb deletion; and Rai1-
targeted disruption.16–18 Craniofacial abnormalities—short,
concave, and/or curved snouts and a broader distance be-
tween the eyes (hypertelorism)—are manifested in each
of these mouse models, but the penetrance is a function
of the size of the deletion interval, as well as the genetic
background. These results indicate that Rai1 is a major
gene responsible for the craniofacial phenotype; however,
genetic elements inside and outside the Df(11)17-1 dele-
tion also contribute to the penetrance of the phenotype.
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Figure 1. Mouse region on chromosome 11 (MMU11) syntenic to the human SMS deletion interval. The corresponding human deletion
regions are shown at the top (bold lines). Shown below are the regions deleted in Df(11)17, Df(11)17-1, and Df(11)17-4 (bold horizontal
lines with vertical lines at ends).
The molecular mechanistic basis of penetrance is essen-
tially unknown.
Previous analyses16–18 have been performed in F1 and
N2 mixed genetic backgrounds. Because of the variations
between the littermates in these backgrounds, we sought
to control the confounding variable of background strain
by making isogenic strains in a pure C57BL/6 background.
This enabled systematic evaluation of the effects of chro-
mosome-engineered deletion size on penetrance of the
craniofacial phenotype. In addition, we created Df(11)17-
4 mice with an ∼1-Mb chromosome-engineered deletion
intermediate in size between the largest 2-Mb deletion
(Df(11)17) and the smallest 590-kb deletion (Df(11)17-1),
to further investigate the effects of deletion size on the
penetrance of the craniofacial phenotype. Our results con-
ﬁrmed the inﬂuence of the genetic background on the
craniofacial phenotype and revealed that the major mod-
ifying genetic element(s) for penetrance in the SMS syn-
tenic region is located within the genomic interval in-
cluded in the Df(11)17-1 deletion; this region includes
Rai1 and surrounding sequences. The multiple contribu-
tions to the penetrance of the craniofacial phenotype in
the SMSmouse models suggest that subtle changes in Rai1
expression levels and/or developmental timing of expres-
sion may underlie penetrance. Such studies will not only
enable better understanding of phenotypic variation in
patients with SMS but may also elucidate the mechanisms
of penetrance.
Detailed methods for surface three-dimensional crani-
ofacial scanning have been described elsewhere.17 Mice
were anesthetized using Avertin (Sigma), their fur was
painted with a mixture of cornstarch and water to create
a white, reﬂective surface for scanning, and they were
scanned on a Cyberware Desktop 3D Scanner. Once
scanned, the ﬁles were edited and converted to .3ds ex-
tensions with the use of the Cyberware Mtool software.
The .3ds ﬁles were opened on free VIScam Solid Viewer
software (Marcam Engineering), facial anatomical land-
mark points were identiﬁed and marked, and their three-
dimensional coordinates were recorded.
The Df(11)17-4 deletion was created by a retrovirus-me-
diated chromosome-engineeringmethod used similarly to
construct Df(11)17-1.17,19 After characterization with FISH
and Southern analysis for detection of the proviral-host
junction fragment (data not shown), virus-insertion-site
ampliﬁcation PCR20 was performed to obtain the precise
genomic coordinates for the virus insertion site. The se-
quence was subjected to BLAST analysis against themouse
genomic sequence (National Center for Biotechnology In-
formation [NCBI] mouse genome resources), which lo-
cated the virus insertion site between the Gtlf3b and
Tmem11 genes (ﬁg. 1). The insertion site was ∼1 Mb telo-
meric to Csn3, which was the starting point for all our
deletions.
The craniofacial phenotype observed in Df(11)17-4/
mice at the N2 generation was similar to that observed in
Df(11)17/ and Df(11)17-1/ animals,16,17 as well as to
that seen in animals with targeted disruption of one copy
of Rai1 (i.e., Rai1/).18 The visual observation was con-
ﬁrmed by quantitative analyses with three-dimensional
craniofacial scans and skeleton measurements (data not
shown). The penetrance was 59%, which, remarkably, was
between that of Df(11)17/ (70%–80%)17 and Df(11)17
-1/ (48%)17 mice (table 1). Because N2 is a mixed back-
ground (25% 129/SvEv and 75% C57BL/6), which con-
veys variation of the craniofacial phenotype between the
littermates, we increased the number of Df(11)17-1/
mice analyzed. The penetrance increased from the 37%
reported elsewhere17 to 48%. The penetrance rate differ-
ence between Df(11)17/ and Df(11)17-1/ mice was
statistically signiﬁcant, whereas the differences between
Df(11)17/ andDf(11)17-4/mice and betweenDf(11)17-
4/ and Df(11)17-1/mice were not. The rate differences
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Table 1. Penetrance of the Craniofacial Phenotype in
Different SMS Mouse Models at the N2 Generation (25%
129SvEvBrd and 75% C57BL/6)
Straina
Deletion
Size
No. of Mice
Penetrance
(%)Examined
With
Phenotype
Df(11)17/b ∼2 Mb 150 … 70–80
Df(11)17-4/c ∼1 Mb 49 29 59
Df(11)17-1/ ∼590 kb 54 26 48
Rai1/d NAe 56 10 18
a All strains were maintained by backcrossing to C57BL/6 Tyrc-Brd (B6)
wild-type mice. Animals were treated in compliance with relevant animal
welfare policies under a protocol approved by the Baylor Institutional
Animal Care and Use Committee. For the penetrance comparison, Fisher’s
exact test was performed. P values !.05 were considered statistically
signiﬁcant.
b Data from Yan et al.17
c Genotyping was performed with two pairs of primers: 5′ HPRT 2Ty
(tyrosinase end) forward 5′-CTGGGAGAAAACATATTTTGAGAGA-3′ and re-
verse 5′-TTCCTGTTTGGGGTAGAATGTACT-3′ and 3033-2 5′-TCCCGATCAAGGTC-
AGGAACA-3′ and B1IN-R 5′-AAAAAGAAGTCAGGGGTTGG-3′.
d Data from Bi et al.18
e NA p not applicable.
Table 2. Penetrance of the Craniofacial Phenotype in
Different SMS Mouse Models in a Pure Isogenic C57BL/6
Background
Strain
Genotype Generation
No. of Mice
Penetrance
(%)Examined
With
Phenotype
Df(11)17/ N8 49 47 96
Df(11)17-1/ N6 30 30 100
Rai1/ N6 28 18 64
between each of the three deletion mice and the Rai1/
mice were statistically signiﬁcant (table 1).
Because of the variability of expression of the crani-
ofacial phenotype between littermates in a mixed back-
ground, and to remove the confounding effects of strain
background from systematic evaluations of engineered de-
letion mutations and the Rai1 null allele, we analyzed the
SMS mouse models in a relatively pure C57BL/6 back-
ground (N6 or N8 generations with 198% B6). The pen-
etrance increased for all pure strains in comparison with
the mixed N2 background (table 2). Df(11)17/ and
Df(11)17-1/mice had a similar penetrance rate (96% and
100%, respectively), whereas that for the Rai1/mice was
signiﬁcantly lower (64%). The P values for comparison of
Rai1/ with Df(11)17/ and Rai1/ with Df(11)17-1/ in
a pure C57BL/6 background were both .001.
Soft-tissue three-dimensional surface scan analysis pro-
vides a rapid, robust, and objective means to assess the
craniofacial phenotype without sacriﬁcing themice.18 The
obtained images conﬁrmed our visual observations (ﬁg.
2A and 2B). Several landmarks were selected to obtain
quantitative measurements, including the distances be-
tween the eyes and the lengths of the snouts (ﬁg. 2B and
2C). Both Df(11)17/ and Df(11)17-1/ mice had signif-
icantly larger distances between the eyes (i.e., hypertelor-
ism) and shorter snouts (i.e., midface hypoplasia),whereas
Rai1/ mice had only shorter snouts. This ﬁnding per-
sisted even after the exclusion of the Rai1/mice without
observable craniofacial phenotype.
Skeletal analyses during necropsy revealed that themost
striking change in the mutants was the deformed nasal
bone (ﬁg. 3A–3H). Several distances were measured, in-
cluding the distance between the anterior notches on the
frontal processes and the distance between the nasale and
anterior notches on the frontal processes, corresponding
to the distance between the eyes and the length of the
nasal bone, respectively (ﬁg. 3A and 3B). The measure-
ments of each of these three mutant strains conﬁrmed
signiﬁcant hypertelorism and shorter nasal bones (ﬁg. 3I).
Interestingly, by this pathological analysis, the same four
measurements differed in a statistically signiﬁcant way for
each of the three isogenic SMS mouse models (ﬁg. 3I).
Thus, there was no observable variability of expression
among the three different Rai1 haploinsufﬁciencymodels
(Df(11)17/, Df(11)17-1/, and Rai1/; the largest and
smallest deletion mutations and the knockout allele, re-
spectively), but there was absolutely clear and signiﬁcantly
reduced penetrance in the Rai1/ animals.
Haploinsufﬁciency of RAI1 has been suggested to be re-
sponsible for the majority of the SMS clinical features,
including the craniofacial abnormalities.11,12,21 Rai1 was
identiﬁed as a gene induced by retinoic acid, which is
known to be involved in craniofacial development.22,23
During mouse embryo development, Rai1 is expressed in
the craniofacial components derived from branchial
arches.18 Furthermore, several lines of evidence indicate
that Rai1 is a potential transcription factor containing an
extended plant homeodomain zinc ﬁnger.12,14 All these ob-
servations explain the involvement of Rai1 in craniofacial
development. Because of the variation of phenotypes in
patients with SMS deletions8 and in those with point mu-
tations,11–14 and because of the ∼50 genes (NCBI human
genome resources) present in the common 3.7-Mb dele-
tion, it is challenging to determine whether RAI1 is the
only gene responsible for the phenotype. Whether one
gene, several contiguous genes, or position effects due to
rearrangement contribute to the phenotype is a question
pertinent to all microdeletion syndromes.24 With the cre-
ation of different mouse models, we were able to dem-
onstrate that genomic regions outside Rai1 apparently
contribute to the penetrance of the phenotype or at least
to craniofacial abnormalities.16–18 By further analyzing
these models in a relatively pure genetic background, we
provide apodictic evidence that, within the SMS syntenic
region,majormodifying genetic element(s) for penetrance
of the craniofacial features resides in the Df(11)17-1 de-
letion, which is an ∼590-kb genomic interval surrounding
the 94-kb Rai1 gene with 68 kb of 5′ and 107 bp of 3′
ﬂanking sequences until the next genes, Pemt and Srebf1,
respectively (ﬁg. 1).
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Figure 2. Three-dimensional craniofacial scan analyses. A and B, Top and side views of the three-dimensional scans of Df(11)17/,
Df(11)17-1/, and Rai1/ mice. C, Statistical analyses of the distances between landmarks. Student’s t test function in Microsoft
Excel (Microsoft Ofﬁce 2001) was used. P values !.05 were considered statistically signiﬁcant. Mean  SEM values are presented.
Landmarks are as follows: tragion (t), endocanthion (en), exocanthion (ex), vertex (v), subnasale (sn), nasion (n), gnathion (gn), and
tip of the ear (sa). WT p wild type; asterisks indicate . Df(11)17/ deletion (DEL) , WT ; Df(11)17-1/ DELP ! .05 np 17 np 22
, WT ; Rai1 / DEL , WT .np 23 np 19 np 28 np 17
One possible explanation for the difference in pene-
trance could relate to the gene content of the smallest
590-kb chromosome-engineered deletion. This 590-kb in-
terval is highly syntenic to the corresponding human
region.9,15 There are 11 genes mapped to this region so far.
In addition to Rai1, targeted disruptions of Csn3, Rasd1,
Pemt, and Srebf1 have been reported.25–28 No heterozygotes
of these four strains were reported to manifest an observ-
able craniofacial phenotype, although such a subtle clin-
ical ﬁnding might be missed without systematic evalua-
tion, because of the low penetrance rate or the less-severe
phenotype. The potential role of the remaining six genes
in craniofacial development needs to be further investi-
gated. Nt5m is a mitochondrial deoxyribonucleotidase,
which may protect mtDNA replication from overproduc-
tion of deoxythymidine triphosphate.29 Flj10193 is a sub-
unit of the multiprotein mediator complex, which is a
coactivator for activation of RNA polymerase II transcrip-
tion.30 Tom1l2, the “target of myb 1–like 2” gene, has been
suggested to modulate endosomal functions31 and has
been shown to negatively regulate the Src mitogenic sig-
naling induced by platelet-derived growth factor.32 Atp12
is required for assembly of F1-ATPase.33 Nonetheless, chro-
mosome-engineered deletions of different sizes (e.g., the
2-Mb Df(11)17 and the 590-kb Df(11)17-1) (table 2) that
have different genes deleted have the same penetrance.
Furthermore, the difference in penetrance is observed be-
tween the deletion strains and the knockout allelewithout
any variability of expression (table 2 and ﬁg. 3). Thus, if
it is a gene in this region that is responsible for the dif-
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Figure 3. Skeleton analyses. Side and top views of skeleton preparations of a wild-type mouse (A and B), a Df(11)17/ mouse (C
and D), a Df(11)17-1/ mouse (E and F), and a Rai1/ mouse (G and H) are presented. I, Measurement results for Df(11)17/ mice
(DEL , WT ), Df(11)17-1/ mice (DEL , WT ), and Rai1 / mice (DEL , WT ). Mean  SEMnp 17 np 28 np 18 np 13 np 19 np 12
values are presented. Landmarks used for the measurements are labeled (A and B): a and c p anterior notches on frontal processes
situated laterally in relation to the infraorbital ﬁssure, bp nasale, dp intersection of parietal and interparietal bones, ep intersection
of interparietal and occipital bones at the midline, f p bregma, and g p intersection of zygoma with zygomatic process of temporal
superior aspect.43 WT p wild type; asterisk indicates . Skeleton preparations were performed as follows. Mice were sacriﬁced,P ! .05
skinned, eviscerated, and dehydrated in 95% ethanol (EtOH). After the staining of cartilage with 0.05% alcian blue 8GX solution, mice
were rinsed in 95% EtOH and were cleared in 2% KOH. Alizarin red (0.015% in 1% KOH) was then used to stain the bones, followed
by clearing in 1% KOH and 20% glycerol. Images were obtained with Image Pro Plus software (Media Cybernetics) and were analyzed
using Adobe Photoshop version 5.5 (Adobe Systems).
ference in penetrance, this gene must affect the craniofa-
cial development in a very similar way as Rai1. Expression
analysis and gene targeting in mice will provide more in-
formation about their potential contribution to the SMS
phenotype or synergistic effects with Rai1.
Importantly, all four of our SMS mouse models have
one intact wild-type chromosome with one normal Rai1
gene (ﬁg. 4). In isogenic strains, the only genomic differ-
ences are either an insertionally inactivated Rai1 gene (ﬁg.
4E) or a complete deletion of one copy of Rai1 and sur-
rounding genomic sequences on the chromosome in trans
to the wild-type chromosome (ﬁg. 4B–4D). The craniofa-
cial phenotype results from the remaining wild-type Rai1
gene on the ﬁxed wild-type chromosome, whereas the
changes in penetrance most likely relate to the variable
changes on the mutated chromosome in trans (ﬁg. 4B–
4E). An alternative potential explanation for the reduced
penetrance in different SMS models and for the speciﬁc
observation that Rai1 null alleles caused by deletion can
have phenotypic consequences different from a null allele
due to gene inactivation is the removal of key control
elements for Rai1. Our mouse models have demonstrated
that Rai1 is a dosage-sensitive gene,16,18,34 as suggested by
human studies involving patients with heterozygous
RAI1 point mutations.11,12,14,21 Rai1 was identiﬁed as a ret-
inoic acid–induced gene, and a retinoic acid response el-
ement was found just upstream of exon 1.22,35 Other than
that, the expression control of this gene remains largely
unknown.
Conserved noncoding sequence analysis provides one
way to predict potential regulatory modules,36,37 and a
regulatory potential (RP) score evaluates the similarity
extent to patterns found in alignments of known regu-
latory elements in comparison to the alignments of neu-
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Figure 4. Chromosome-engineered and Rai1-knockout mouse models of SMS. Left, Genomic structure of the critical region on human
17p11.2 and the syntenic interval in mouse. The two chromosome homologues, represented by horizontal lines, are shown for each of
the ﬁve strains studied, including wild type (WT) (A), three chromosome-engineered deletions with the region deleted demarcated by
an absent horizontal line ﬂanked by parenthesis at the break points (B–D), and the Rai1-knockout allele marked by an asterisk (E).
Top, Individual genes within the interval examined. The shaded gray background represents the experimentally manipulated chromosome,
whereas the ﬁxed or constant chromosome is not shaded. Right, Details of the ﬁve strains studied. Note that there is essentially no
change in penetrance for the deletion mutants (boxes), whereas there is reduced penetrance (triangle) for the knockout allele. NA p
not available. ND p not determined.
tral DNA.38,39 There is a region ∼8 kb upstream of the
mouse Rai1 gene that is highly conserved in human, rat,
and chimp and that shows high RP scores (ﬁve-way RP:
human, chimp, dog, mouse, and rat [UCSC Genome
Browser]).
“Position effects” refer to alterations of gene expression
due to a change in genomic position and, thus, gain or
loss of the regulatory modules acting in cis.40,41 Trans reg-
ulation of gene expression is less well studied, particularly
in mammalian species. Transvection, the inﬂuence of a
gene’s expression by the pairing of alleles on homologous
chromosomes, is one mechanism for trans regulation.42 As
in cis regulation,40,41 the inﬂuence of trans regulation is
likely to have greater phenotypic consequences and effects
in the case of dosage-sensitive genes. The lower pene-
trance in Rai1/ mice could result from the interaction
between the remaining control element in the targeted
allele and the normal allele, whereas, in deletion muta-
tions, the surrounding sequences are lost. Alternatively,
trans-regulatory elements affectingRai1 expression through
other mechanisms could potentially have been removed
in different deletions. Different deletion sizes may also
inﬂuence the phenotype through a position effect by re-
moval or retention of the control element for a pheno-
type-causing gene located outside the deletions.
The differences in penetrance between two lines with
adjacent deletion sizes were small at the N2 generation
(Df(11)17/, 70%80%;Df(11)17-4/, 59%; andDf(11)17-
1/, 48%), and there was essentially no difference be-
tween Df(11)17/ (96%) and Df(11)17-1/ (100%) at the
N6 or N8 generations. These latter two deletions differ in
the genes deleted—Df(11)17 deletes ∼34 genes, whereas
Df(11)17-1 deletes only ∼11—yet they have essentially
identical penetrances for the craniofacial phenotype.
These ﬁndings are most consistent with potential regu-
latory sequences, rather than the absence of genes in-
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cluded in distinct deletions, being responsible for the
penetrance difference. Regardless of genes deleted in the
isogenic background, we observed similar penetrance. Re-
duced penetrance in the isogenic background was ob-
served only for the Rai1 null allele constructed by inser-
tional inactivation and not for deﬁciency alleles.
This study further narrowed the region for the major
modifying genetic element(s) in the penetrance of the
craniofacial phenotype in mouse models of SMS. The con-
struction of isogenic strains for the different Rai1 hap-
loinsufﬁciency mutation models of SMS apparently un-
couples variability of expression from penetrance. Our
ﬁnding of the lack of variability of phenotypic expression
between the Rai1/ and deletion models in the context
of reduced penetrance suggests that the modifying ele-
ment(s) either functions in a very similar way as Rai1 in
craniofacial development or results in subtle changes in
dosage or expression of Rai1, perhaps during speciﬁc time
intervals of development. In each of the four different
mutation models studied, the craniofacial phenotype re-
sults from the wild-type Rai1 gene on the ﬁxed or constant
wild-type chromosome, whereas the penetrance differ-
ence is associated with changes—a knockout allele (ﬁg.
4E) versus chromosome-engineered deletions (ﬁg. 4B and
4D)—on the trans-manipulated chromosome. Future stud-
ies to elucidate such potential modifying element(s) will
enrich our knowledge of not only the molecular mecha-
nism for SMS but also craniofacial development in general
and, perhaps, will reveal insights into the molecular basis
of penetrance.
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